Lithium and Decreased Sexual Libido
Yes, lithium can cause decreased sexual libido, and this is a well-documented adverse effect that occurs in approximately 20-31% of patients on long-term lithium monotherapy.
Evidence from Clinical Guidelines and Research
The most direct evidence comes from clinical practice guidelines addressing psychotropic medications and sexual dysfunction. Most psychotropic drugs can affect libido or erectile function, either through a direct action or by increasing prolactin or decreasing testosterone levels 1. While the guideline discussing premature ejaculation notes that lithium can interact with serotonin reuptake inhibitors to cause serotonergic syndrome 2, it does not specifically list lithium as a primary cause of decreased libido in that context.
However, the FDA drug label for lithium does not explicitly list decreased libido as a labeled adverse effect 3, which represents a significant gap between clinical experience and official labeling.
Clinical Research Findings
The research evidence is more definitive:
In a 2020 multicenter study of 114 euthymic bipolar patients, those on lithium monotherapy had significantly worse sexual desire compared to those on anticonvulsants alone 4. The lithium group also demonstrated worse sexual arousal scores.
A 2006 Italian study found that 30% of patients on long-term lithium monotherapy attributed their sexual problems directly to lithium introduction 5. These patients showed significantly reduced sexual desire (37.3% vs 9.5% in controls) and fewer sexual fantasies (25.4% vs 13.6% in controls).
A 1996 study of 35 bipolar men on lithium monotherapy found that 31.4% reported sexual dysfunction, with 23% experiencing reduced frequency of sexual thoughts 6. Notably, 20% reported loss of erection during sex.
Mechanisms of Action
The pathophysiology involves both central and peripheral mechanisms 7:
- Central effects: Lithium may reduce sexual thoughts and desire through effects on neurotransmitter systems
- Peripheral effects: Preclinical studies suggest lithium can reduce testosterone levels and impair nitric oxide-mediated relaxation of cavernosal tissue 8
Clinical Implications and Management
The sexual dysfunction associated with lithium appears to primarily affect desire and arousal phases rather than pleasure or satisfaction 6. Importantly, most patients in studies reported preserved pleasure during sexual activity despite reduced desire.
Key Clinical Considerations:
- Concomitant benzodiazepine use with lithium increases the risk of sexual dysfunction 4, 8, so avoid this combination when possible
- Anticonvulsants (valproate or lamotrigine) in monotherapy have the least negative effects on sexual function compared to lithium 4
- Sexual dysfunction with lithium is significantly associated with lower overall functioning and may reduce medication compliance 8
Management Algorithm:
- Screen proactively for sexual dysfunction at baseline and during follow-up visits, as patients may not spontaneously report these symptoms
- If decreased libido develops on lithium monotherapy: Consider switching to anticonvulsant mood stabilizers (valproate or lamotrigine), which show better sexual function profiles 4
- If lithium must be continued: Avoid adding benzodiazepines, which worsen sexual dysfunction 4
- Check testosterone and prolactin levels to identify reversible hormonal causes 1
- Consider dose reduction if lithium levels are at the higher end of therapeutic range, though no clear correlation exists between serum lithium levels and sexual dysfunction severity 6
Important Caveats
- This adverse effect is significantly under-researched and under-reported 8, with only 13 relevant clinical papers identified in systematic reviews
- The FDA label does not mention sexual dysfunction, highlighting a disconnect between clinical experience and official documentation 3
- A 2024 FAERS database analysis identified lithium as having a potential signal for decreased libido that was not mentioned in its prescribing information 9
- The degree of sexual dysfunction may not always cause patient distress or non-compliance 6, but this should not minimize its importance for quality of life
The evidence strongly supports that lithium causes decreased sexual libido through multiple mechanisms, affecting 20-30% of patients, with desire and arousal being most impacted while pleasure remains relatively preserved.